Potassium Hydroxide → Bactroban

HRID 16677

反応式

HRID 16677 の反応式
[CH3:1][C@@H:2]([C@@H:33]([OH:35])[CH3:34])[C@@H:3]1[O:5][C@H:4]1[CH2:6][C@@H:7]1[C@@H:12]([OH:13])[C@@H:11]([OH:14])[C@H:10]([CH2:15]/[C:16](/[CH3:32])=[CH:17]/[C:18]([O:20][CH2:21][CH2:22][CH2:23][CH2:24][CH2:25][CH2:26][CH2:27][CH2:28][C:29]([OH:31])=[O:30])=[O:19])[O:9][CH2:8]1.[OH-].[K+].[Cl-].[Ca+2:39].[Cl-].[CH3:41][C@@H:42]([C@@H:73]([OH:75])[CH3:74])[C@@H:43]1[O:45][C@H:44]1[CH2:46][C@@H:47]1[C@@H:52]([OH:53])[C@@H:51]([OH:54])[C@H:50]([CH2:55]/[C:56](/[CH3:72])=[CH:57]/[C:58]([O:60][CH2:61][CH2:62][CH2:63][CH2:64][CH2:65][CH2:66][CH2:67][CH2:68][C:69]([OH:71])=[O:70])=[O:59])[O:49][CH2:48]1.[K]>CO>[CH3:1][C@H:2]([C@H:3]1[C@H:4]([CH2:6][C@H:7]2[CH2:8][O:9][C@@H:10]([CH2:15]/[C:16](/[CH3:32])=[CH:17]/[C:18]([O:20][CH2:21][CH2:22][CH2:23][CH2:24][CH2:25][CH2:26][CH2:27][CH2:28][C:29]([O-:31])=[O:30])=[O:19])[C@H:11]([OH:14])[C@@H:12]2[OH:13])[O:5]1)[C@H:33]([CH3:34])[OH:35].[CH3:41][C@H:42]([C@H:43]1[C@H:44]([CH2:46][C@H:47]2[CH2:48][O:49][C@@H:50]([CH2:55]/[C:56](/[CH3:72])=[CH:57]/[C:58]([O:60][CH2:61][CH2:62][CH2:63][CH2:64][CH2:65][CH2:66][CH2:67][CH2:68][C:69]([O-:71])=[O:70])=[O:59])[C@H:51]([OH:54])[C@@H:52]2[OH:53])[O:45]1)[C@H:73]([CH3:74])[OH:75].[Ca+2:39]

参加物

6

反応条件

温度
24.5 °C

実験手順

Pseudomonic acid (220 g) was dissolved in methanol (210 ml) kept at 25-27° C. Separately, potassium hydroxide (27.9 g) was dissolved in methanol (154 ml). Also separately, calcium chloride (24.39 g) was dissolved in methanol (133 ml). The potassium hydroxide solution was added to the pseudomonic acid solution until obtaining a pH=9.4-9.5 (147 ml of potassium hydroxide solution was added.). The calcium chloride solution was then added to the mupirocin potassium solution until reaching a pH=7.6-7.7 (128 ml of calcium chloride solution was added.). The solution was stirred at 24-25° C. for an hour. Potassium chloride was filtered, and the solution was labeled Solution B. Solution B (25 ml) was added to diisopropyl-ether (250 ml) at (−7)° C. while stirring. Solid amorphous mupirocin calcium precipitated from the solution, and was stirred at −7° C. for 3 h. The solid product was filtered and washed with cold diisoprpyl-ether (10 ml). The product was dried in a fluidized bed dryer for 6 hours at 35° C., and then in a vacuum oven for 12 h at 35° C.

後処理

  1. customkept at 25-27° C
  2. customuntil obtaining
  3. filtrationPotassium chloride was filtered
  4. additionSolution B (25 ml) was added to diisopropyl-ether (250 ml) at (−7)° C
  5. stirringwhile stirring
  6. customSolid amorphous mupirocin calcium precipitated from the solution
  7. stirringwas stirred at −7° C. for 3 h
  8. filtrationThe solid product was filtered
  9. washwashed with cold diisoprpyl-ether (10 ml)
  10. customThe product was dried in a fluidized bed dryer for 6 hours at 35° C.
  11. customfor 12 h
  12. customat 35° C.

出典と根拠

ORDレコード
ord-21d687e9fc524443be04ee0bd85f33bb
出典データセット
uspto-grants-2010_06
特許番号
US07737177B2

関連ノート

読み込み中…